Immune recognition and tumor protection
- 20 February 2002
- journal article
- editorial
- Published by Elsevier in Current Opinion in Immunology
- Vol. 14 (2) , 161-164
- https://doi.org/10.1016/s0952-7915(02)00315-1
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- CD4+T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody productionProceedings of the National Academy of Sciences, 2001
- Infections as a major preventable cause of human cancerJournal of Internal Medicine, 2000
- Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responsesProceedings of the National Academy of Sciences, 2000
- Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICAScience, 1999
- Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICBProceedings of the National Academy of Sciences, 1999
- New Paths in Human Cancer SerologyThe Journal of Experimental Medicine, 1998
- Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanomaCancer, 1996
- Human tumor antigens recognized by T lymphocytes.The Journal of Experimental Medicine, 1996
- Human neoplasms elicit multiple specific immune responses in the autologous host.Proceedings of the National Academy of Sciences, 1995
- Model Predicting Survival in Stage I Melanoma Based on Tumor ProgressionJNCI Journal of the National Cancer Institute, 1989